Therapy-related ovarian dysfunction in women treated for Hodgkin's disease.
D000328:Adult; D000477:Alkylating Agents / Q000627:therapeutic use; D000568:Amenorrhea / Q000209:etiology; D003131:Combined Modality Therapy; D004958:Estradiol / Q000097:blood; D005260:Female; D005298:Fertility / Q000187:drug effects; D006062:Gonadotropins / Q000097:blood; D006689:Hodgkin Disease / Q000150:complications* / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D008597:Menstrual Cycle / Q000187:drug effects*; D008875:Middle Aged; D010049:Ovarian Diseases / Q000209:etiology* / Q000503:physiopathology; D011344:Procarbazine / Q000627:therapeutic use
D000477:Alkylating Agents; D006062:Gonadotropins; D011344:Procarbazine; D004958:Estradiol